CD4 and colorectal carcinoma: WT CRC (10.31 ± 2.66%) and MIF−/− CRC (9.34 ± 1.91%) mice showed higher percentages of CD4+ T cells than their healthy controls (WT 1.621 ± 0.1413% vs. MIF−/−1.097 ± 0.2190%).